Geon Woo Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Geon Woo Lee has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Heon Jong Yoo
Department of Obstetrics & Gynecology, Chungnam National University Sejong Hospital, Sejong, Korea
5 shared publications - Jae-Weon Kim
Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea
4 shared publications Soo Youn Song
Department of Obstetrics and Gynecology, Chungnam National University School of Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea
4 shared publications- Allen Gideon Tan
Department of Obstetrics and Gynecology, University of the Philippines Manila, Manila, Philippines
3 shared publications - Angela Cho
Department of Obstetrics and Gynecology, Jeju National University Hospital, Jeju National University College of Medicine, Jeju, Korea
3 shared publications - Biswajit Dash
Department of Gynecological Oncology, Tata Memorial Hospital, HBNI University, Mumbai, India
3 shared publications
Latest Publications
- Open Access
- 1 January 2027
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 38
Current status of fertility preservation for borderline ovarian tumor in Asian regions: results from ASGO-special task force for fertility preservation; part I. Fertility-sparing treatment for borderline ovarian tumor
Kuji S, et al. J Gynecol Oncol. 2027 ;38:e24. https://doi.org/10.3802/jgo.2027.38.e24
- 1 January 2027
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 38
Open AccessCurrent status of fertility preservation for borderline ovarian tumor in Asian regions: results from ASGO-special task force for fertility preservation; part I. Fertility-sparing treatment for borderline ovarian tumor
Kuji S, et al. J Gynecol Oncol. 2027 ;38:e24. https://doi.org/10.3802/jgo.2027.38.e24
- Open Access
- 1 January 2027
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 38
Current status of fertility preservation for borderline ovarian tumor in Asian countries: results from ASGO-special task force for fertility preservation; part II. Fertility and pregnancy planning following initial treatment
Kuji S, et al. J Gynecol Oncol. 2027 ;38:e21. https://doi.org/10.3802/jgo.2027.38.e21
- 1 January 2027
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 38
Open AccessCurrent status of fertility preservation for borderline ovarian tumor in Asian countries: results from ASGO-special task force for fertility preservation; part II. Fertility and pregnancy planning following initial treatment
Kuji S, et al. J Gynecol Oncol. 2027 ;38:e21. https://doi.org/10.3802/jgo.2027.38.e21
- Open Access
- 1 January 2027
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 38
The real-world practice of fertility preservation for patients with epithelial ovarian cancer in Asian regions
Yoshihara M, et al. J Gynecol Oncol. 2027 ;38:e17. https://doi.org/10.3802/jgo.2027.38.e17
- 1 January 2027
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 38
Open AccessThe real-world practice of fertility preservation for patients with epithelial ovarian cancer in Asian regions
Yoshihara M, et al. J Gynecol Oncol. 2027 ;38:e17. https://doi.org/10.3802/jgo.2027.38.e17
- Open Access
- 28 April 2025
- Published by Springer Nature in BMC Surgery
- Vol. 25  (1) , 1-8
Outcomes of cesarean myomectomy in Singleton compared with twin pregnancies: a 10-year retrospective cohort study
To evaluate and compare the pregnancy outcomes after cesarean myomectomy in singleton and twin pregnancies. We retrospectively reviewed 100 pregnant women diagnosed with myoma who underwent cesarean myomectomy at Chungnam National University Hospital between January 2012 and July 2022. Of them, 77 were singleton pregnancies and 23 were twin pregnancies. Maternal characteristics, largest myoma size, number of myomas, and surgical outcomes were compared between two groups. Myomas were further categorized based on their size; large myomas were defined as lesions measuring ≥ 5 cm in diameter. Maternal characteristics, preoperative and postoperative hemoglobin levels, operative time, and length of hospital stay were compared between the two subgroups. Continuous variables were compared using the Mann–Whitney U test, and categorical variables were assessed using the chi-square test. No significant differences were observed in the maternal characteristics, largest myoma size, number of myomas, or surgical outcomes between singleton and twin pregnancies. However, subgroup analysis based on the largest myoma size (≥ 5 vs. 0.999). No patient required interventions, such as the insertion of an intrauterine Foley balloon, uterine artery embolization, or hysterectomy. Cesarean myomectomy is safe and effective in both singleton and twin pregnancies, even in patients with large myomas.
- 28 April 2025
- Published by Springer Nature in BMC Surgery
- Vol. 25  (1) , 1-8
Open AccessOutcomes of cesarean myomectomy in Singleton compared with twin pregnancies: a 10-year retrospective cohort study
To evaluate and compare the pregnancy outcomes after cesarean myomectomy in singleton and twin pregnancies. We retrospectively reviewed 100 pregnant women diagnosed with myoma who underwent cesarean myomectomy at Chungnam National University Hospital between January 2012 and July 2022. Of them, 77 were singleton pregnancies and 23 were twin pregnancies. Maternal characteristics, largest myoma size, number of myomas, and surgical outcomes were compared between two groups. Myomas were further categorized based on their size; large myomas were defined as lesions measuring ≥ 5 cm in diameter. Maternal characteristics, preoperative and postoperative hemoglobin levels, operative time, and length of hospital stay were compared between the two subgroups. Continuous variables were compared using the Mann–Whitney U test, and categorical variables were assessed using the chi-square test. No significant differences were observed in the maternal characteristics, largest myoma size, number of myomas, or surgical outcomes between singleton and twin pregnancies. However, subgroup analysis based on the largest myoma size (≥ 5 vs. 0.999). No patient required interventions, such as the insertion of an intrauterine Foley balloon, uterine artery embolization, or hysterectomy. Cesarean myomectomy is safe and effective in both singleton and twin pregnancies, even in patients with large myomas.
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 36  (6)
Developing standardized informed consent for hysterectomy and vulva cancer surgery
Oh S, et al. J Gynecol Oncol. 2025 Apr;36:e107. https://doi.org/10.3802/jgo.2025.36.e107
- 1 January 2025
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 36  (6)
Open AccessDeveloping standardized informed consent for hysterectomy and vulva cancer surgery
Oh S, et al. J Gynecol Oncol. 2025 Apr;36:e107. https://doi.org/10.3802/jgo.2025.36.e107
- Top Cited PapersOpen Access
- 23 October 2023
- Published by MDPI AG in Biomedicines
- Vol. 11  (10) , 2868
Endometriosis-Related Chronic Pelvic Pain
Endometriosis, which is the presence of endometrial stroma and glands outside the uterus, is one of the most frequently diagnosed gynecologic diseases in reproductive women. Patients with endometriosis suffer from various pain symptoms such as dysmenorrhea, dyspareunia, and chronic pelvic pain. The pathophysiology for chronic pain in patients with endometriosis has not been fully understood. Altered inflammatory responses have been shown to contribute to pain symptoms. Increased secretion of cytokines, angiogenic factors, and nerve growth factors has been suggested to increase pain. Also, altered distribution of nerve fibers may also contribute to chronic pain. Aside from local contributing factors, sensitization of the nervous system is also important in understanding persistent pain in endometriosis. Peripheral sensitization as well as central sensitization have been identified in patients with endometriosis. These sensitizations of the nervous system can also explain increased incidence of comorbidities related to pain such as irritable bowel disease, bladder pain syndrome, and vulvodynia in patients with endometriosis. In conclusion, there are various possible mechanisms behind pain in patients with endometriosis, and understanding these mechanisms can help clinicians understand the nature of the pain symptoms and decide on treatments for endometriosis-related pain symptoms.
- 23 October 2023
- Published by MDPI AG in Biomedicines
- Vol. 11  (10) , 2868
Top Cited PapersOpen AccessEndometriosis-Related Chronic Pelvic Pain
Endometriosis, which is the presence of endometrial stroma and glands outside the uterus, is one of the most frequently diagnosed gynecologic diseases in reproductive women. Patients with endometriosis suffer from various pain symptoms such as dysmenorrhea, dyspareunia, and chronic pelvic pain. The pathophysiology for chronic pain in patients with endometriosis has not been fully understood. Altered inflammatory responses have been shown to contribute to pain symptoms. Increased secretion of cytokines, angiogenic factors, and nerve growth factors has been suggested to increase pain. Also, altered distribution of nerve fibers may also contribute to chronic pain. Aside from local contributing factors, sensitization of the nervous system is also important in understanding persistent pain in endometriosis. Peripheral sensitization as well as central sensitization have been identified in patients with endometriosis. These sensitizations of the nervous system can also explain increased incidence of comorbidities related to pain such as irritable bowel disease, bladder pain syndrome, and vulvodynia in patients with endometriosis. In conclusion, there are various possible mechanisms behind pain in patients with endometriosis, and understanding these mechanisms can help clinicians understand the nature of the pain symptoms and decide on treatments for endometriosis-related pain symptoms.
- 20 August 2020
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 41  (4) , 605-611
Usefulness of sentinel lymph node mapping using indocyanine green and fluorescent imaging in the diagnosis of lymph node metastasis in endometrial cancer
The lymph node status is the most important prognostic factor for endometrial cancer. This study aimed to assess whether sentinel lymph node mapping (SLNM) is applicable in endometrial cancer. A retrospective review of patients with endometrial cancer who were diagnosed and treated in Asan Medical Centre from September 2015 to December 2017 was conducted. One hundred patients underwent robotic (da Vinci®) or laparoscopic surgical treatment, including SLNM with indocyanine green (ICG) fluorescence detection using the Firefly® and NIR/ICG systems. At least one lymph node area was observed in 100% of SLNM cases. Sentinel node detection and frozen biopsy were performed in all cases, and all patients with metastasis were found on SLNM. The sensitivity and negative predictive value were both 100% in the patient-by-patient and station-by-station analyses. SLNM appears to be a feasible method to reduce the morbidity and increase the detection rate in early-stage endometrial carcinoma.
- 20 August 2020
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 41  (4) , 605-611
Usefulness of sentinel lymph node mapping using indocyanine green and fluorescent imaging in the diagnosis of lymph node metastasis in endometrial cancer
The lymph node status is the most important prognostic factor for endometrial cancer. This study aimed to assess whether sentinel lymph node mapping (SLNM) is applicable in endometrial cancer. A retrospective review of patients with endometrial cancer who were diagnosed and treated in Asan Medical Centre from September 2015 to December 2017 was conducted. One hundred patients underwent robotic (da Vinci®) or laparoscopic surgical treatment, including SLNM with indocyanine green (ICG) fluorescence detection using the Firefly® and NIR/ICG systems. At least one lymph node area was observed in 100% of SLNM cases. Sentinel node detection and frozen biopsy were performed in all cases, and all patients with metastasis were found on SLNM. The sensitivity and negative predictive value were both 100% in the patient-by-patient and station-by-station analyses. SLNM appears to be a feasible method to reduce the morbidity and increase the detection rate in early-stage endometrial carcinoma.
- Open Access
- 1 January 2020
- Published by Wolters Kluwer Health in Medicine
- Vol. 99  (1) , e18653
Effect of serotonin-norepinephrine reuptake inhibitors for patients with chemotherapy-induced painful peripheral neuropathy
Background: To compare the efficacy of serotonin-norepinephrine reuptake inhibitors (SNRIs) treatment for chemotherapy-induced peripheral neuropathy (CIPN) Methods: Two authors independently searched MEDLINE, Embase, Cochran Library, and Web of Science to identify and review articles published from January 1998 until December 2018 according to selection criteria. Outcomes were expressed as mean difference, the pooled odds ratio, or relative risk in a meta-analysis model. Results: A total of 10 studies were included in this meta-analysis: 6 randomized-controlled studies and 4 observational studies. Meta-analysis showed that CIPN was improved after treatment with SNRI (standardized mean difference = 2.20; 95% confidence interval, 0.90–3.49; I 2 = 93% in 3 randomized controlled studies). Somnolence and insomnia occurred in <15% of patients. Incidence of somnolence was lower than with pregabalin treatment, and insomnia was comparable to that in expectant management or pregabalin treatment. Incidence of nausea and vomiting was higher than in expectant management, but no significant difference was found when compared to expectant management. Conclusion: From the several available studies suitable for indirect comparison, SNRI shows excellent efficacy and tolerability to CIPN. SNRI could provide an important treatment option for CIPN.
- 1 January 2020
- Published by Wolters Kluwer Health in Medicine
- Vol. 99  (1) , e18653
Open AccessEffect of serotonin-norepinephrine reuptake inhibitors for patients with chemotherapy-induced painful peripheral neuropathy
Background: To compare the efficacy of serotonin-norepinephrine reuptake inhibitors (SNRIs) treatment for chemotherapy-induced peripheral neuropathy (CIPN) Methods: Two authors independently searched MEDLINE, Embase, Cochran Library, and Web of Science to identify and review articles published from January 1998 until December 2018 according to selection criteria. Outcomes were expressed as mean difference, the pooled odds ratio, or relative risk in a meta-analysis model. Results: A total of 10 studies were included in this meta-analysis: 6 randomized-controlled studies and 4 observational studies. Meta-analysis showed that CIPN was improved after treatment with SNRI (standardized mean difference = 2.20; 95% confidence interval, 0.90–3.49; I 2 = 93% in 3 randomized controlled studies). Somnolence and insomnia occurred in <15% of patients. Incidence of somnolence was lower than with pregabalin treatment, and insomnia was comparable to that in expectant management or pregabalin treatment. Incidence of nausea and vomiting was higher than in expectant management, but no significant difference was found when compared to expectant management. Conclusion: From the several available studies suitable for indirect comparison, SNRI shows excellent efficacy and tolerability to CIPN. SNRI could provide an important treatment option for CIPN.
- 6 June 2019
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 300  (3) , 737-750
Effect of pretreatment with combined oral contraceptives on outcomes of assisted reproductive technology for women with polycystic ovary syndrome: a meta-analysis
To evaluate the effect of pretreatment with combined oral contraceptives (COC) on outcomes in women with polycystic ovary syndrome (PCOS) who underwent assisted reproductive technology for subfertility.
- 6 June 2019
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 300  (3) , 737-750
Effect of pretreatment with combined oral contraceptives on outcomes of assisted reproductive technology for women with polycystic ovary syndrome: a meta-analysis
To evaluate the effect of pretreatment with combined oral contraceptives (COC) on outcomes in women with polycystic ovary syndrome (PCOS) who underwent assisted reproductive technology for subfertility.
- 1 December 2018
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 231, 85-92
Efficacy of levonorgestrel releasing intrauterine system as a postoperative maintenance therapy of endometriosis: A meta-analysis
- 1 December 2018
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 231, 85-92
Efficacy of levonorgestrel releasing intrauterine system as a postoperative maintenance therapy of endometriosis: A meta-analysis